|

Paroxetine Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Mostafa Bahaa1
  • BioNTech SE1

Indications

  • Arthritis1
  • Rheumatoid Arthritis1
  • Advanced Solid Tumor1
  • Lung Cancer1
  • Cancer1

Other1 trial

Paroxetine Safety and Efficacy in Rheumatoid Arthritis
Phase 3

San Francisco, California1 trial

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.